| Literature DB >> 32055314 |
Chao Li1, Yi-Xuan Cao1, Ruo-Xing Jin1, Kang-Jie Bian1, Zi-Yang Qin1, Quan Lan1, Xi-Sheng Wang1.
Abstract
A nickel-catalyzed difluoroalkylation of α-C-H bonds of aryl ketones to furnish highly stereo-defined tetrasubstituted monofluoroalkenes or quaternary alkyl difluorides from secondary or tertiary ketones, respectively, has been established. Mechanistic investigations indicated that these C-H fluoroalkylations proceed via a Ni(i)/Ni(iii) catalytic cycle. An obvious fluorine effect was observed in the reaction, and this reaction has demonstrated high stereoselectivity, mild conditions, and broad substrate scopes, thus enabling the late-stage fluoroalkylation of bioactive molecules. This method offers a solution for expedient construction of monofluoroalkenes from readily available materials, and provides an efficient approach for the synthesis of bioactive fluorinated compounds for the discovery of lead compounds in medicinal chemistry. This journal is © The Royal Society of Chemistry 2019.Entities:
Year: 2019 PMID: 32055314 PMCID: PMC7003883 DOI: 10.1039/c9sc02806d
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Scheme 1Biologically active molecules containing stereodefined monofluoroalkenes.
Scheme 2Nickel-catalyzed difluoroalkylation of alkyl reagents.
Nickel-catalyzed arylfluoroalkylation: optimization of conditions
|
| |||||
| Entry | Ni source | Ligand | Base |
| Yield |
| 1 | NiCl2(PPh3)2 | XantPhos | LDA | 4 : 1 | 85 |
| 2 | NiCl2(PPh3)2 | XantPhos | LDA | 7 : 1 | 72 |
| 3 | NiCl2(PPh3)2 | XantPhos | LDA | >99 : 1 | 91 |
| 4 | NiCl2(PPh3)2 | XantPhos |
| — | Trace |
| 5 | NiCl2(PPh3)2 | XantPhos | LiHMDS | >99 : 1 | 59 |
| 6 | NiCl2(PPh3)2 | XantPhos | KHMDS | >99 : 1 | 44 |
| 7 | NiCl2 | XantPhos | LDA | >99 : 1 | 45 |
| 8 | Ni(OTf)2 | XantPhos | LDA | >99 : 1 | 14 |
| 9 | NiCl2·glyme | XantPhos | LDA | >99 : 1 | 61 |
| 10 | Ni(COD)2 | XantPhos | LDA | >99 : 1 | 85 |
| 11 | NiCl2(PPh3)2 | PPh3 | LDA | >99 : 1 | 38 |
| 12 | NiCl2(PPh3)2 | P(1-Naph)3 | LDA | >99 : 1 | 32 |
| 13 | NiCl2(PPh3)2 | dppBz | LDA | >99 : 1 | 32 |
| 14 | NiCl2(PPh3)2 | Phen | LDA | >99 : 1 | 36 |
| 15 | NiCl2(PPh3)2 | dmbPy | LDA | >99 : 1 | 20 |
| 16 | NiCl2(PPh3)2 | IPr·HCl | LDA | >99 : 1 | 18 |
| 17 | NiCl2(PPh3)2 | XantPhos | LDA | >99 : 1 | 91 |
| 18 | NiCl2(PPh3)2 | XantPhos | LDA | >99 : 1 | 62 |
| 19 | — | XantPhos | LDA | — | Trace |
Unless otherwise noted, the reaction conditions were as follows: 1a (0.2 mmol), 2 (3.0 equiv.), [Ni] (10 mol%), ligand (10 mol%), base (105 mol%), solvent (2.0 mL), –10 °C, 12 h, N2.
E/Z ratio was determined by 19F NMR analysis.
Yields of the isolated products given.
BrCF2CO2Et was used as 2a.
BrCF2CONEt2 was used as 2b.
T = –30 °C.
T = 0 °C. XantPhos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene, dmbPy = 4,4′-dimethyl-2,2′-bipyridine, dppBz = 1,2-bis(diphenylphosphino)benzene, Phen = 1,10-phenanthroline.
Nickel-catalyzed difluoroalkylation of 2° aryl ketones to monofluoroalkenes
|
|
Reaction conditions: 1 (0.2 mmol, 1.0 equiv.), 2 (0.6 mmol, 3.0 equiv.), NiCl2(PPh3)2 (10 mol%), XantPhos (10 mol%), LDA (105 mol%), THF (2.0 mL), –10 °C, 12 h, under a N2 atmosphere. E/Z > 99 : 1. XantPhos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene.
Nickel-catalyzed difluoroalkylation of 3° aryl ketones to alkyl difluorides
|
|
Reaction conditions: 4 (0.2 mmol, 1.0 equiv.), 2 (3.0 equiv.), NiCl2·dppe (10 mol%), XantPhos (10 mol%), LDA (105 mol%), ZnCl2 (0.2 equiv.), THF (2.0 mL), –10 °C, 12 h, under a N2 atmosphere. XantPhos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene.
Scheme 3The synthetic application of monofluoroalkenes.
Scheme 4Late-stage modification of biologically active complex molecules.
Scheme 5Fluorine effect.
Scheme 6Mechanistic studies.
Scheme 7The possible reaction mechanism.